Corton Capital Inc. Travere Therapeutics, Inc. Transaction History

Corton Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.44 - $9.5 $71,873 - $125,514	-13,212 Reduced 44.34%	16,584 $149,000
Q3 2023 Nov 14, 2023	BUY	$7.64 - $17.25 $227,641 - $513,981	29,796 New	29,796 $266,000
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $315,169 - $408,479	-13,349 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $324,914 - $416,088	13,349 New	13,349 $414,000

198

84.9M

776K

912K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.